Episode
14 Reasons Why Psychopharmacology Differs in Women, Part 1
- Published
- Jun 22, 2026
- Duration seconds
- 1052
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-carlat-psychiatry-podcast-491560/episodes/14-reasons-why-psychopharmacology-differs-in-women-part-1/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-carlat-psychiatry-podcast-491560/14-reasons-why-psychopharmacology-differs-in-women-part-1.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Women and men respond to psychiatric medications differently. In this first of a four-part series, Chris Aiken and Kellie Newsome walk through why valproate is risky for women, and when it’s worth using; why the FDA cut the zolpidem dose in half for female patients, and why SSRIs outperform tricyclics in women with depression. Plus: a sneak preview of DSM-6. CME: Take the CME Post-Test for this Episode Published On: 06/22/2026 Duration: 27 minutes, 32 seconds Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.